Cargando…

Correction to: SNCG promotes the progression and metastasis of high-grade serous ovarian cancer via targeting the PI3K/AKT signaling pathway

Detalles Bibliográficos
Autores principales: Zhang, Jing, Liu, Xiao-han, Li, Cong, Wu, Xiao-xing, Chen, Yan-lin, Li, Wen-wen, Li, Xian, Gong, Fan, Tang, Qin, Jiang, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301439/
https://www.ncbi.nlm.nih.gov/pubmed/32552756
http://dx.doi.org/10.1186/s13046-020-01596-w
_version_ 1783547690158653440
author Zhang, Jing
Liu, Xiao-han
Li, Cong
Wu, Xiao-xing
Chen, Yan-lin
Li, Wen-wen
Li, Xian
Gong, Fan
Tang, Qin
Jiang, Dan
author_facet Zhang, Jing
Liu, Xiao-han
Li, Cong
Wu, Xiao-xing
Chen, Yan-lin
Li, Wen-wen
Li, Xian
Gong, Fan
Tang, Qin
Jiang, Dan
author_sort Zhang, Jing
collection PubMed
description
format Online
Article
Text
id pubmed-7301439
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73014392020-06-18 Correction to: SNCG promotes the progression and metastasis of high-grade serous ovarian cancer via targeting the PI3K/AKT signaling pathway Zhang, Jing Liu, Xiao-han Li, Cong Wu, Xiao-xing Chen, Yan-lin Li, Wen-wen Li, Xian Gong, Fan Tang, Qin Jiang, Dan J Exp Clin Cancer Res Correction BioMed Central 2020-06-17 /pmc/articles/PMC7301439/ /pubmed/32552756 http://dx.doi.org/10.1186/s13046-020-01596-w Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Zhang, Jing
Liu, Xiao-han
Li, Cong
Wu, Xiao-xing
Chen, Yan-lin
Li, Wen-wen
Li, Xian
Gong, Fan
Tang, Qin
Jiang, Dan
Correction to: SNCG promotes the progression and metastasis of high-grade serous ovarian cancer via targeting the PI3K/AKT signaling pathway
title Correction to: SNCG promotes the progression and metastasis of high-grade serous ovarian cancer via targeting the PI3K/AKT signaling pathway
title_full Correction to: SNCG promotes the progression and metastasis of high-grade serous ovarian cancer via targeting the PI3K/AKT signaling pathway
title_fullStr Correction to: SNCG promotes the progression and metastasis of high-grade serous ovarian cancer via targeting the PI3K/AKT signaling pathway
title_full_unstemmed Correction to: SNCG promotes the progression and metastasis of high-grade serous ovarian cancer via targeting the PI3K/AKT signaling pathway
title_short Correction to: SNCG promotes the progression and metastasis of high-grade serous ovarian cancer via targeting the PI3K/AKT signaling pathway
title_sort correction to: sncg promotes the progression and metastasis of high-grade serous ovarian cancer via targeting the pi3k/akt signaling pathway
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301439/
https://www.ncbi.nlm.nih.gov/pubmed/32552756
http://dx.doi.org/10.1186/s13046-020-01596-w
work_keys_str_mv AT zhangjing correctiontosncgpromotestheprogressionandmetastasisofhighgradeserousovariancancerviatargetingthepi3kaktsignalingpathway
AT liuxiaohan correctiontosncgpromotestheprogressionandmetastasisofhighgradeserousovariancancerviatargetingthepi3kaktsignalingpathway
AT licong correctiontosncgpromotestheprogressionandmetastasisofhighgradeserousovariancancerviatargetingthepi3kaktsignalingpathway
AT wuxiaoxing correctiontosncgpromotestheprogressionandmetastasisofhighgradeserousovariancancerviatargetingthepi3kaktsignalingpathway
AT chenyanlin correctiontosncgpromotestheprogressionandmetastasisofhighgradeserousovariancancerviatargetingthepi3kaktsignalingpathway
AT liwenwen correctiontosncgpromotestheprogressionandmetastasisofhighgradeserousovariancancerviatargetingthepi3kaktsignalingpathway
AT lixian correctiontosncgpromotestheprogressionandmetastasisofhighgradeserousovariancancerviatargetingthepi3kaktsignalingpathway
AT gongfan correctiontosncgpromotestheprogressionandmetastasisofhighgradeserousovariancancerviatargetingthepi3kaktsignalingpathway
AT tangqin correctiontosncgpromotestheprogressionandmetastasisofhighgradeserousovariancancerviatargetingthepi3kaktsignalingpathway
AT jiangdan correctiontosncgpromotestheprogressionandmetastasisofhighgradeserousovariancancerviatargetingthepi3kaktsignalingpathway